Grants paid by Cure Kcnh1 Foundation
EIN 87-2041980 · Encinitas, CA · Form 990, Schedule I · NTEE H01
Cure Kcnh1 Foundation of Encinitas, CA (EIN 87-2041980) reported 4 grants paid totaling $168,400 to 2 recipients in tax years 2025, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$168,400
4 grants
Recipients
2
distinct organizations
Tax years
2025
1 filing in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2025 | 4 | $168,400 | — |
Top recipients
The 2 recipients receiving the most from Cure Kcnh1 Foundation, by grants paid, out of 2 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Northwestern University 36-2167817 | B | Evanston, IL | 3 | $150,000 | 2025 |
| N-Lorem Foundation 84-3288113 | A | Carlsbad, CA | 1 | $18,400 | 2025 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 4 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2025 | Northwestern University Evanston, IL | B | $100,000 | paid | Funded the launch of a CRISPR gene-editing project a true cure for KCNH1 disorders. | 202641359349307754 |
| 2025 | Northwestern University Evanston, IL | B | $30,000 | paid | Established a biorepository to collect patient-derived bio samples to fund the development of cell lines that will be used to develop disease-models and screen therapeutics for KCNH1. | 202641359349307754 |
| 2025 | Northwestern University Evanston, IL | B | $20,000 | paid | Funded the ongoing development of antisense oligonucleotides RNA therapeutics for KCNH1 this treatment is showing very promising results in mouse studies. | 202641359349307754 |
| 2025 | N-Lorem Foundation Carlsbad, CA | A | $18,400 | paid | Funded the final stages of preclinical development of an allele selective antisense oligonucleotide RNA therapeutic for KCNH1. | 202641359349307754 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990 | 2025 | 2025-12-31 | not stated | 2025v4.0 | 202641359349307754 |
Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/872041980.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.